Based in Israel, Barcode Nanotech is a startup.
Barcode Nanotech develops proprietary lipid-based nanoparticles for the targeted delivery of RNA and DNA therapeutics and vaccines to specific tissues and tumors, enabling selective RNA therapeutic delivery beyond the liver.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.